You are here

A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Birmingham, Alabama, 35233 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Diarrhea
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Antiretroviral-naive patients with HIV-1 infection

- not more than 2 loose stools per day or any preexisting or emerging medical condition
that would interfere with the evaluation of therapeutic response of the study drug

- No antidiarrheal medication within 7 days prior to entry

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Greater than or equal to 2 loose stools per day lasting 2 or more days within 7 days
prior to study entry

- Bloody stools within 7 days prior to study entry

- Any unstable or severe intercurrent medical condition, including active opportunistic
infections

NCT00650637
Pfizer
Terminated
A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now